NCT06695845 2026-02-25A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsJazz PharmaceuticalsPhase 2 Recruiting200 enrolled
NCT04325828 2026-02-13YATAGARASUJanssen Pharmaceutical K.K.Phase 2 Active not recruiting31 enrolled 15 charts
NCT04969835 2026-02-04A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursAvacta Life Sciences LtdPhase 1 Recruiting158 enrolled